本页面由Tiger Trade Technology Pte. Ltd.提供服务

Pasithea Therapeutics Corp.

0.4220
-0.0255-5.70%
成交量:4.29万
成交额:1.81万
市值:1,410.09万
市盈率:-0.28
高:0.4500
开:0.4500
低:0.4100
收:0.4475
52周最高:2.06
52周最低:0.2810
股本:3,341.44万
流通股本:1,020.20万
量比:0.58
换手率:0.42%
股息:- -
股息率:- -
每股收益(TTM):-1.4820
每股收益(LYR):-2.9100
净资产收益率:-65.49%
总资产收益率:-36.00%
市净率:0.28
市盈率(LYR):-0.15

数据加载中...

2023/03/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/10

重要事件披露

8-K - Current report
2023/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/24

重要事件披露

8-K - Current report
2023/01/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/14

重要事件披露

8-K - Current report
2022/12/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/12

重要事件披露

8-K - Current report
2022/09/21

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/20

重要事件披露

8-K - Current report
2022/09/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/29

重要事件披露

8-K/A [Amend] - Current report
2022/08/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/11

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership